Foundayo and Zepbound now covered for millions of Americans
Foundayo and Zepbound now covered for millions of Americans
PR Newswire
INDIANAPOLIS, May 28, 2026
View original content to download multimedia:https://www.prnewswire.com/news-releases/foundayo-and-zepbound-now-covered-for-millions-of-americans-302784360.htmlSOURCE Eli Lilly and Company
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months,…
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs will be…
Lilly's Foundayo and Zepbound gain CVS Caremark formulary coverage, expanding access for 90 million members at $25 monthly…
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
The agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for…
The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will
Lilly's Foundayo and Zepbound to gain CVS coverage, lifting sales outlook
